Jpmorgan Chase & CO Anika Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 37,145 shares of ANIK stock, worth $444,997. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,145
Previous 82,491 54.97%
Holding current value
$444,997
Previous $1.36 Million 58.88%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$15.03 - $17.97 $681,550 - $814,867
-45,346 Reduced 54.97%
37,145 $558,000
Q4 2024

Feb 12, 2025
BUY
$16.04 - $25.53 $1.07 Million - $1.71 Million
66,982 Added 431.89%
82,491 $1.36 Million
Q3 2024

Dec 26, 2024
SELL
$24.25 - $28.75 $268,496 - $318,320
-11,072 Reduced 41.65%
15,509 $383,000
Q3 2024

Nov 08, 2024
SELL
$24.25 - $28.75 $268,496 - $318,320
-11,072 Reduced 41.65%
15,509 $383,000
Q2 2024

Dec 26, 2024
BUY
$24.57 - $28.47 $272,039 - $315,219
11,072 Added 71.39%
26,581 $673,000
Q2 2024

Aug 12, 2024
SELL
$24.57 - $28.47 $19,508 - $22,605
-794 Reduced 2.9%
26,581 $673,000
Q1 2024

Dec 26, 2024
BUY
$21.95 - $26.42 $260,458 - $313,499
11,866 Added 76.51%
27,375 $695,000
Q1 2024

May 10, 2024
SELL
$21.95 - $26.42 $65,279 - $78,573
-2,974 Reduced 9.8%
27,375 $695,000
Q4 2023

Dec 26, 2024
BUY
$18.47 - $23.3 $274,094 - $345,772
14,840 Added 95.69%
30,349 $687,000
Q4 2023

Feb 12, 2024
BUY
$18.47 - $23.3 $295,833 - $373,196
16,017 Added 111.76%
30,349 $687,000
Q3 2023

Nov 14, 2023
SELL
$16.98 - $26.1 $63,505 - $97,614
-3,740 Reduced 20.69%
14,332 $267,000
Q2 2023

Aug 11, 2023
BUY
$25.16 - $28.86 $78,901 - $90,504
3,136 Added 21.0%
18,072 $469,000
Q1 2023

May 18, 2023
BUY
$25.91 - $32.1 $289,336 - $358,460
11,167 Added 296.29%
14,936 $428,000
Q1 2023

May 11, 2023
SELL
$25.91 - $32.1 $194,195 - $240,589
-7,495 Reduced 66.54%
3,769 $108,000
Q4 2022

Feb 13, 2023
BUY
$23.85 - $31.91 $15,693 - $20,996
658 Added 6.2%
11,264 $334,000
Q3 2022

Nov 14, 2022
BUY
$21.74 - $24.68 $18,609 - $21,126
856 Added 8.78%
10,606 $253,000
Q2 2022

Aug 11, 2022
BUY
$20.4 - $25.53 $24,439 - $30,584
1,198 Added 14.01%
9,750 $218,000
Q1 2022

May 11, 2022
SELL
$24.7 - $36.54 $30,282 - $44,798
-1,226 Reduced 12.54%
8,552 $215,000
Q4 2021

Feb 10, 2022
BUY
$35.83 - $45.03 $112,577 - $141,484
3,142 Added 47.35%
9,778 $350,000
Q3 2021

Nov 12, 2021
BUY
$38.75 - $44.47 $257,145 - $295,102
6,636 New
6,636 $282,000

Others Institutions Holding ANIK

# of Institutions
112
Shares Held
11.3M
Call Options Held
1.2K
Put Options Held
1.4K
View Full List

About Anika Therapeutics, Inc.

ANIK Quotes by TradingView
  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $175M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email